Dr. Boudreau investigates how human natural killer cell immunogenetics program immune responsiveness to cancer and infectious diseases. She uses bioinformatics, humanized in vivo models, cell-signal analysis, and highly-parametric flow cytometry to understand how genetic variation creates diversity in human immune potentials.

Her interdisciplinary and collaborative work aims to translate research findings into precision therapies.